Skip to content

Bills · Sep 2011 Special Session

AB 13

Died at session end Official bill text Atom feed

providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.

  1. Introduced, stopped here
  2. Passes Assembly, not reached
  3. Passes Senate, not reached
  4. Governor signs, not reached
  5. Law, not reached

Unfamiliar terms? Glossary

What this bill does

Plain-language analysis by the nonpartisan Legislative Reference Bureau

This bill provides immunity from liability to a manufacturer or a seller of a drug

or device for any claim based on strict liability for a defect in the drug or device if the

drug or device was approved by the federal Food and Drug Administration (FDA) at

the time the drug or device left the control of the manufacturer or seller. The bill also

provides immunity from liability to a manufacturer or seller of a drug or device for

any claim based on the failure to warn of the risk of the drug or device if labeling for

the drug or device was made available to the consumer or the person who prescribed

the drug or device and the labeling was in compliance with applicable standards

established by the FDA at the time the drug or device left the control of the

manufacturer or seller.

The bill defines a "device" as an instrument, apparatus, implement, machine,

contrivance, implant, in vitro reagent or other similar or related article, including

any component, part, or accessory, which does not achieve any of its principal

intended purposes through chemical action within or on the body of a person or other

animal, is not dependent upon being metabolized for the achievement of any of its

principal intended purposes, and is: (a) recognized by the U.S. pharmacopoeia and

national formulary or official homeopathic pharmacopoeia of the United States, or

any supplement to either of them; (b) intended for use in the diagnosis, cure,

mitigation, treatment, or prevention of disease or other conditions in persons or other

animals; or (c) intended to affect the structure or any function of the body of persons

or other animals. The bill defines a "drug" as: 1) any substance recognized as a drug

in the official U.S. pharmacopoeia and national formulary or official homeopathic

pharmacopoeia of the United States or any supplement to either of them; 2) any

substance intended for use in the diagnosis, cure, mitigation, treatment, or

prevention of disease or other conditions in persons or other animals; 3) any

substance other than a device or food intended to affect the structure or any function

of the body of persons or other animals; or 4) any substance intended for use as a

component of any article specified in items 1) to 3), above, but does not include gases

or devices or articles intended for use or consumption in or for mechanical, industrial,

manufacturing, or scientific applications or purposes. The bill defines a

"manufacturer" as an entity licensed or approved by the FDA to engage in the

manufacture of drugs or devices. The bill defines an "entity" as a corporation,

partnership, or association.

Sponsors

Introduced by: Committee on Assembly Organization , Representative Kooyenga , Senator Zipperer , by request of Governor Scott Walker

2 cosponsors

Kooyenga (R) , Zipperer (R)

Full history

  1. Oct 11, 2011 · Assembly

    Introduced by committee on Assembly Organization, by request of Governor Scott Walker, Representative Kooyenga, and Senator Zipperer

  2. Oct 11, 2011 · Assembly

    Read first time and referred to committee on Judiciary and Ethics

  3. Oct 11, 2011 · Assembly

    Representative Kooyenga added as a coauthor

  4. Oct 11, 2011 · Assembly

    Senator Zipperer added as a cosponsor

  5. Dec 13, 2011 · Assembly

    Failed to pass pursuant to Senate Joint Resolution 1